Valuation: SciBase Holding AB

Market Cap 351M 35.9M 31.57M 29.33M 26.98M 50.59M 3.48B 51.49M 137M 1.7B 135M 132M 5.88B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 351M 35.9M 31.57M 29.33M 26.98M 50.59M 3.48B 51.49M 137M 1.7B 135M 132M 5.88B EV / Sales 2026 *
5.32x
EV / Sales 2027 * 3.37x
Free-Float
77.17%
Yield 2026 *
-
Yield 2027 * -
1 day+3.63%
1 week-2.56%
Current month+5.54%
1 month+4.57%
3 months-16.34%
6 months+54.50%
Current year-0.58%
1 week 32
Extreme 32
35.3
1 month 29.65
Extreme 29.65
37
Current year 18.5
Extreme 18.5
54
1 year 18.5
Extreme 18.5
54
3 years 18.5
Extreme 18.5
148.4
5 years 18.5
Extreme 18.5
657
10 years 18.5
Extreme 18.5
3,020
Manager TitleAgeSince
Chief Executive Officer 59 2023-09-30
Director of Finance/CFO 64 2013-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2017-05-15
Chairman 66 2024-06-12
Director/Board Member 68 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.63%-2.56%-7.30%-70.38% 35.9M
-1.22%-10.11%+13.05%-39.02% 15.63B
+9.95%+6.85%+9.30%+115.26% 1.79B
-0.60%-9.10%-37.67%-80.94% 1.13B
-2.78%-5.23%-38.51%+10.60% 960M
+0.57%-6.27%-29.58%-53.93% 630M
+2.48%-10.19%-47.94%-56.93% 517M
+0.56%-0.37%+39.40%-53.79% 452M
+0.17%-5.10%-57.50%-61.99% 359M
+0.14%-5.71%-22.28%-39.78% 339M
Average +1.27%-2.32%-17.90%-33.09% 2.18B
Weighted average by Cap. -0.15%-7.06%+3.98%-27.99%

Financials

2026 *2027 *
Net sales 65.9M 6.74M 5.93M 5.51M 5.07M 9.51M 653M 9.68M 25.7M 319M 25.32M 24.77M 1.11B 104M 10.66M 9.38M 8.71M 8.01M 15.03M 1.03B 15.3M 40.64M 504M 40.04M 39.17M 1.75B
Net income -66.3M -6.79M -5.97M -5.54M -5.1M -9.56M -657M -9.73M -25.86M -321M -25.48M -24.92M -1.11B -51.5M -5.27M -4.64M -4.31M -3.96M -7.43M -510M -7.56M -20.09M -249M -19.79M -19.36M -864M
Net Debt - -
Logo SciBase Holding AB
SciBase Holding AB (publ) is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. SciBase Holding AB (publ) specializes in early detection and prevention in dermatology. The Company develops and commercializes Nevisense, a point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. SciBase Holding AB (publ) combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer.
Employees
49
Date Price Change Volume
26-07-23 SEK 34.30 +3.63% 1,551
26-07-22 SEK 33.10 -4.06% 3,611
26-07-21 SEK 34.50 -2.27% 90
26-07-20 SEK 35.30 0.00% 44
26-07-17 SEK 35.30 +0.28% 2,057

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCIB Stock